COMMUNIQUÉS West-GlobeNewswire

Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases
17/08/2026
RAD 101 Phase 2b trial demonstrated 93% concordance with MRI across all evaluable lesions, meeting the Phase 2 trial's primary endpoint End-of-Phase 2 meeting with the U.S. FDA scheduled for October 1 st , 2026; on [...]
Montauk Brewing Company Expands Its Coastal Footprint with New North Shore Brewpub
17/08/2026
Beloved Long Island craft beer brand opens its second taproom, bringing fresh brews, beach-town energy and Montauk’s come-as-you-are spirit to Port Jefferson MONTAUK, N.Y., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Montauk [...]
Zelluna receives Independent Data Monitoring Committee recommendation to continue patient enrolment in ZIMA-101
17/08/2026
Independent Data Monitoring Committee (IDMC) recommends recruitment of the next two patients at the first dose level First patient completed the planned first treatment cycle with no serious adverse events or dose- [...]
Tilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary
17/08/2026
Launch connects Tilray Medical’s European cultivation and pharmaceutical manufacturing capabilities with Lyphe Clinic and Lyphe Dispensary to expand direct patient access across the UK and advance Tilray’s integrated [...]
Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update
17/08/2026
Completed acquisition of Azora Therapeutics, adding AT177, a fully synthetic, oral, colon-targeted aryl hydrocarbon receptor (“Ahr”) agonist in development for ulcerative colitis, to its pipeline Closed initial $32 [...]
Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026
17/08/2026
Dividend to be Paid Consistent with the Company's Cash Dividend Policy REHOVOT, Israel and HOBOKEN, N.J., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company [...]
SEED Therapeutics Nominated for 2026 Prix Galien USA “Best Start-Up” Award
17/08/2026
Second Consecutive Nomination Recognizes SEED’s Progress in Rational Molecular Glue Development and Targeted Protein Degradation Recognition Follows First-in-Human Proof of Mechanism for Lead RBM39 Degrader ST-01156 in [...]
Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies
17/08/2026
Combined company to operate as Slate Medicines and focus on advancing Slate's portfolio of next-generation migraine therapeutics Slate’s lead product candidate, SLTE-1009, is a clinical stage, potentially best-in-class [...]
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET
17/08/2026
Key recent and second quarter highlights include: Completed first-cycle FDA review of the Company’s ANDA for preservative-free ketamine with no drug-related major deficiencies. The sole remaining item, a manufacturer's [...]
EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU™ 2.7mg in Wet AMD
17/08/2026
– DURAVYU was non-inferior to on-label aflibercept control (nominal p-value = 0.0096) in an ad hoc analysis excluding a 4% asymmetric cohort (9 of 211 patients) who experienced vision loss (≥ 15 letters) unrelated to [...]
Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer
17/08/2026
The New Mechanistic Findings Support Can-Fite’s Ongoing Phase IIb Study Design Following Positive Phase IIa Results Ramat Gan, Israel, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd . (NYSE American: CANF) ( [...]
InspireMD Reports Second Quarter 2026 Financial Results
17/08/2026
- Company to host investor conference call today, August 17 th , at 8:30am EDT - MIAMI, Aug. 17, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard ® Prime [...]
GHK-Cu Peptide Launched By Kylo Peptides for Laboratory Research Applications
17/08/2026
Sheridan,Wyoming, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides [ https://kylopeptides.com ] has added GHK-Cu peptide to its catalog of laboratory research materials, expanding the range of copper-binding compounds [...]
Zelluna ASA: Notice of EGM – experienced international biotech executive proposed for election to the Board and Board member steps down
17/08/2026
Oslo, 17 August 2026: The Board of Directors of Zelluna ASA (the “Company”) hereby calls for an Extraordinary General Meeting to be held on 9 September 2026 at 13:00 CEST, regarding election of a new member of the [...]
AB Science announces the successful settlement and delivery of securities issued as part of its €14.2 million private placement announced on August 10, 2026
17/08/2026
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL SETTLEMENT AND DELIVERY OF SECURITIES ISSUED AS PART OF ITS €14.2 MILLION PRIVATE PLACEMENT ANNOUNCED ON AUGUST 10, 2026 Paris, August 17, 2026, 7.30am CET AB Science S. [...]
AB Science annonce le succès du règlement-livraison des titres émis dans le cadre de son placement privé de 14,2 millions d’euros annoncé le 10 aout 2026
17/08/2026
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LE SUCCES DU REGLEMENT-LIVRAISON DES TITRES EMIS DANS LE CADRE DE SON PLACEMENT PRIVE DE 14,2 MILLIONS D’EUROS ANNONCE LE 10 AOUT 2026 Paris, 17 août 2026, 7h30 AB Science S.A. ( [...]
argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
17/08/2026
Study met primary endpoint of mean Total Improvement Score (TIS) at Week 52 in the combined study population of IMNM and DM patients (p=0.0011) Patient improvements observed early and sustained throughout study; [...]
Breast Augmentation in Dubai - Why Surgical Planning Matters More Than the Implant
17/08/2026
DUBAI, United Arab Emirates, Aug. 17, 2026 (GLOBE NEWSWIRE) -- With demand for aesthetic treatments continuing to rise across the UAE, women are increasingly seeking procedures of breast augmentation in Dubai that [...]
Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain
17/08/2026
NEW YORK, Aug. 16, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has completed patient treatment in [...]

Pages